Apellis Pharmaceuticals
13F holders, Q2 2026 (June 30)5holders
$0.00avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Apellis Pharmaceuticals in their 13F filings. The largest holders were NBT Bank, N.A. ($0), Financial Gravity Companies, Inc. ($0) and Salomon & Ludwin, LLC ($0).
- Company
- Apellis Pharmaceuticals
- CUSIP
- 037CVR016
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $0 |
| Exits | 0 | $0 |
Ownership 5 holders
| NBT Bank, N.A. | 0.00% | New | 45 | $0 |
| Financial Gravity Companies, Inc. | 0.00% | — | 100 | $0 |
| Salomon & Ludwin, LLC | 0.00% | New | 850 | $0 |
| Archer Investment Corp | 0.00% | New | 500 | $0 |
| GAMMA Investing LLC | 0.00% | New | 981 | $0 |
"% of holder's portfolio" is APELLIS PHARMACEUTICALS's weight in each manager's 13F, not the share of Apellis Pharmaceuticals the manager owns.